Regeneron flags Google antitrust loss, energy suit appeal in US case against Amgen
MLex Summary: Regeneron Pharmaceuticals notified a Delaware federal judge of two rulings the company said support its request for denial of summary judgement to Amgen in an antitrust suit over rebates...To view the full article, register now.
Already a subscriber? Click here to view full article